S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

AUPH Aurinia Pharmaceuticals Inc

7.95

0.00 (0.00%)

Pre Market

Last Updated: 03:09:55

Delayed by 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

Aurinia Pharmaceuticals (NASDAQ:AUPH)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Aurinia Pharmaceuticals Charts.

Aurinia Pharmaceuticals (NASDAQ:AUPH)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Aurinia Pharmaceuticals Charts.

Aurinia Pharmaceuticals Inc News

Aurinia Pharmaceuticals to Release 2024 Fourth Quarter and Full Year Financial and Operational Results on February 27, 2025
Thursday 20 February 2025 (7 days ago) • Business Wire

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 14 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 25 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 25 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 25 November 2024 (3 months ago) • Edgar (US Regulatory)

Aurinia Commends 2024 Updated ACR Guidelines for Screening, Treatment, and Management of Lupus Nephritis
Monday 18 November 2024 (3 months ago) • Business Wire

Aurinia Presents New Data Underscoring Critical Importance of Earlier Lupus Nephritis Detection and Intervention and Value of LUPKYNIS® in Managing LN at American College of Rheumatology Convergence 2024
Friday 15 November 2024 (3 months ago) • Business Wire

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 14 November 2024 (3 months ago) • Edgar (US Regulatory)

Aurinia to Participate in Jefferies London Healthcare Conference
Thursday 14 November 2024 (3 months ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 12 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 7 November 2024 (4 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 7 November 2024 (4 months ago) • Edgar (US Regulatory)

More Aurinia Pharmaceuticals Inc News Articles

TransCode Therapeutics

MineralRite (PK)

CyberFuels (PK)

Valiant Eagle (PK)

Good Vibrations Shoes (PK)

Voip Pal Com (QB)

TPT Global Tech (PK)

Digital Brand Media and ... (PK)

RespireRx Pharmaceuticals (CE)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions